Receptor-guided structure-activity modeling of inhibitors of juvenile hormone epoxide hydrolases

Juvenile Hormones and Juvenoids: Modeling Biological Effects and Environmental Fate

Volumn , Issue , 2013, Pages 267-289

  Caballero, Julio ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

Author keywords

Comparative or homology modeling; Juvenile hormone epoxide hydrolase inhibitors; MM GBSA; Molecular dynamics; Receptor guided structure activity modeling

Indexed keywords

EID: 84907706900     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14899     Document Type: Chapter

References (80)

1. L.M. Riddiford, Molecular aspects of juvenile hormone action in insect metamorphosis, in Metamorphosis, L.I. Gilbert, J.R. Tata, and B. G. Atkinson, eds., Academic Press, Inc., New York, 1996, pp. 223-251.
2. R.M. Roe and K. Venkatesh, Metabolism of juvenile hormones: Degradation and titer regulation, in Morphogenetic Hormones of Arthropods, G.A. Rutgers, ed., Vol. 1, University Press, New Brunswick, NJ, 1990, pp. 126-179.
3. B.D. Hammock, Regulation of juvenile hormone titer: Degradation, in Comprehensive Insect Physiology, Biochemistry and Pharmacology, G.A. Kerkut and L.I. Gilbert, eds., Pergamon Press, Oxford, U.K., 1985, pp. 431-472.
4. L.I. Gilbert, R. Rybczynski, and S.S. Tobe, Endocrine cascade in insect metamorphosis, in Metamorphosis: Post-Embryonic Reprogramming of Gene Expression in Amphibian and Insect Cells, L.I. Gilbert, J.R. Tata, and B. G. Atkinson, eds., Academic Press, Inc., San Diego, CA, 1996, pp. 59-107.
5. A. Tan, H. Tanaka, T. Tamura, and T. Shiotsuki, Precocious metamorphosis in transgenic silkworms overexpressing juvenile hormone esterase, Proc. Natl. Acad. Sci. USA. 102 (2005), pp. 11751-11756.
6. C. Minakuchi and L.M. Riddiford, Insect juvenile hormone action as a potential target of pest management, J. Pestic. Sci. 31 (2006), pp. 77-84.
7. K.H. Hoffmann and M.W. Lorenz, Recent advances in hormones in insect pest control, Phytoparasitica 26 (1998), pp. 323-330.
8. G.B. Staal, Insect control with insect growth regulators based on insect hormones, in Natural Products and the Protection of Plants, G.B. Marini-Bettolo, ed., Pontificia Academia Scientiarum, Roma, Italy, 1977, pp. 253-283.
9. L.P. Pedigo, Entomology and Pest Management, Prentice Hall, Upper Saddle River, NJ, 1996.
10. C. Morisseau, M.H. Goodrow, D. Dowdy, J. Zheng, J.F. Greene, J.R. Sanborn, and B.D. Hammock, Potent urea and carbamate inhibitors of soluble epoxide hydrolases, Proc. Natl. Acad. Sci. U. S. A. 96 (1999), pp. 8849-8854.
11. B. Borhan, A.D. Jones, F. Pinot, D.F. Grant, M.J. Kurth, and B.D. Hammock, Mechanism of soluble epoxide hydrolase. Formation of an alpha-hydroxy ester-enzyme intermediate through Asp-333, J. Biol. Chem. 270 (1995), pp. 26923-26930.
12. H.-F. Tzeng, L.T. Laughlin, S. Lin, and R.N. Armstrong, The catalytic mechanism of microsomal epoxide hydrolase involves reversible formation and rate-limiting hydrolysis of the alkyl-enzyme intermediate, J. Am. Chem. Soc. 118 (1996), pp. 9436-9437.
13. J. Casas, L.G. Harshman, and B.D. Hammock, Epoxide hydrolase activity on juvenile hormone in Manduca sexta, Insect Biochem. 21 (1991), pp. 17-26.
14. L.G. Harshman, J. Casas, E.C. Dietze, and B.D. Hammock, Epoxide hydrolase activities in Drosophila melanogaster, Insect Biochem. 21 (1991), pp. 887-894.
15. R.J. Linderman, R.M. Roe, S.V. Harris, and D.M. Thompson, Inhibition of insect juvenile hormone epoxide hydrolase: asymmetric synthesis and assay of glycidol-ester and epoxy-ester inhibitors of Trichoplusia ni epoxide hydrolase, Insect Biochem. Mol. Biol. 30 (2000), pp. 767-774.
16. T.F. Severson, M.H. Goodrow, C. Morisseau, D.L. Dowdy, and B.D. Hammock, Urea and amide-based inhibitors of the juvenile hormone epoxide hydrolase of the tobacco hornworm (Manduca sexta: Sphingidae), Insect Biochem. Mol. Biol. 32 (2002), pp. 1741-1756.
17. J. Zou, B.M. Hallberg, T. Bergfors, F. Oesch, M. Arand, S.L. Mowbray, and T.A. Jones, Structure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases, Structure 8 (2000), pp. 111-22.
18. J. Caballero and M. Fernández, Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1), Curr. Top. Med. Chem. 8 (2008), pp. 1580-1605.
19. M.T. Cronin, J.S. Jaworska, J.D. Walker, M.H. Comber, C.D. Watts, and A.P. Worth, Use of QSARs in international decision-making frameworks to predict health effects of chemical substances, Environ. Health Perspect. 111 (2003), pp. 1391-1401.
20. P.D. Mosier and P.C. Jurs, QSAR/QSPR studies using probabilistic neural networks and generalized regression neural networks, J. Chem. Inform. Comput. Sci. 42 (2002), pp. 1460-1470.
21. Y. Nakagawa, C.E. Wheelock, C. Morisseau, M.H. Goodrow, B.G. Hammock, and B.D. Hammock, 3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues, Bioorg. Med. Chem. 8 (2000), pp. 2663-2673.
22. K.H. Kim, Outliers in SAR and QSAR: Is unusual binding mode a possible source of outliers?, J. Comput. Aided Mol. Des. 21 (2007), pp. 63-86.
23. M. Garriga and J. Caballero, Insights into the structure of urea-like compounds as inhibitors of the juvenile hormone epoxide hydrolase (JHEH) of the tobacco hornworm Manduca sexta: Analysis of the binding modes and structure-activity relationships of the inhibitors by docking and CoMFA calculations, Chemosphere 82 (2011), pp. 1604-1613.
24. R.D. Cramer, D.E. Patterson, and J.D. Bunce, Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc. 110 (1988), pp. 5959-5967.
25. U. Pieper, N. Eswar, B.M. Webb, D. Eramian, L. Kelly, D.T. Barkan, H. Carter, P. Mankoo, R. Karchin, M.A. Marti-Renom, F.P. Davis, and A. Sali, MODBASE, a database of annotated comparative protein structure models and associated resources, Nucleic Acids Res. (2008), pp. gkn791.
26. M.A. Argiriadi, C. Morisseau, M.H. Goodrow, D.L. Dowdy, B.D. Hammock, and D.W. Christianson, Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation, J. Biol. Chem. 275 (2000), pp. 15265-15270.
27. G.A. Gomez, Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids, Protein Sci. 15 (2006), pp. 58-64.
28. H.M. Berman, T.N. Bhat, P.E. Bourne, Z. Feng, G. Gilliland, H. Weissig, and J. Westbrook, The Protein Data Bank and the challenge of structural genomics, Nat. Struct. Biol. 7 Suppl (2000), pp. 957-959.
29. B. Boeckmann, A. Bairoch, R. Apweiler, M.C. Blatter, A. Estreicher, E. Gasteiger, M.J. Martin, K. Michoud, C. O’Donovan, I. Phan, S. Pilbout, and M. Schneider, The SWISSPROT protein knowledgebase and its supplement TrEMBL in 2003, Nucleic Acids Res. 31 (2003), pp. 365-370.
30. M.A. Marti-Renom, A.C. Stuart, A. Fiser, R. Sanchez, F. Melo, and A. Sali, Comparative protein structure modeling of genes and genomes, Annu. Rev. Biophys. Biomol. Struct. 29 (2000), pp. 291-325.
31. F. Kiefer, K. Arnold, M. Kunzli, L. Bordoli, and T. Schwede, The SWISS-MODEL Repository and associated resources, Nucleic Acids Res. 37 (2009), pp. D387-D392.
32. K.C. Keiser, K.S. Brandt, G.M. Silver, and N. Wisnewski, Cloning, partial purification and in vivo developmental profile of expression of the juvenile hormone epoxide hydrolase of Ctenocephalides felis, Arch. Insect Biochem. Physiol. 50 (2002), pp. 191-206.
33. T. Tsubota, T. Nakakura, and T. Shiotsuki, Molecular characterization and enzymatic analysis of juvenile hormone epoxide hydrolase genes in the red flour beetle Tribolium castaneum, Insect Mol. Biol. 19 (2010), pp. 399-408.
34. S. Harris, D.M. Thompson, R.J. Linderman, M.D. Tomalski, and R.M. Roe, Cloning and expression of a novel juvenile hormone-metabolizing epoxide hydrolase during larval-pupal metamorphosis of the cabbage looper, Trichoplusia ni, Insect Mol. Biol. 8 (1999), pp. 85-96.
35. A. Seino, T. Ogura, T. Tsubota, M. Shimomura, T. Nakakura, A. Tan, K. Mita, T. Shinoda, Y. Nakagawa, and T. Shiotsuki, Characterization of juvenile hormone epoxide hydrolase and related genes in the larval development of the silkworm Bombyx mori, Biosci. Biotechnol. Biochem. 74 (2010), pp. 1421-1429.
36. A.M. Lesk and C. Chothia, The response of protein structures to amino-acid sequence changes, Philos. Trans. R. Soc. Lond. A 317 (1986), pp. 345-356.
37. A.M. Lesk and C. Chothia, How different amino acid sequences determine similar protein structures: the structure and evolutionary dynamics of the globins, J. Mol. Biol. 136 (1980), pp. 225-270.
38. S.Y. Chung and S. Subbiah, A structural explanation for the twilight zone of protein sequence homology, Structure 4 (1996), pp. 1123-1127.
39. J.K. Beetham, D. Grant, M. Arand, J. Garbarino, T. Kiyosue, F. Pinot, F. Oesch, W.R. Belknap, K. Shinozaki, and B.D. Hammock, Gene evolution of epoxide hydrolases and recommended nomenclature, DNA Cell Biol. 14 (1995), pp. 61-71.
40. K.H. Hopmann and F. Himo, Theoretical study of the full reaction mechanism of human soluble epoxide hydrolase, Chem. Eur. J. 12 (2006), pp. 6898-6909.
41. D.W. Borhani and D.E. Shaw, The future of molecular dynamics simulations in drug discovery, J. Comput. Aided Mol. Des. 26 (2012), pp. 15-26.
42. M.C. Payne, M.P. Teter, D.C. Allan, T.A. Arias, and J.D. Joannopoulos, Iterative minimization techniques for ab initio total-energy calculations: Molecular dynamics and conjugate gradients, Rev. Mod. Phys. 64 (1992), pp. 1045-1097.
43. B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, and M. Karplus, CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, J. Comput. Chem. 4 (1983), pp. 187-217.
44. W.D. Cornell, P. Cieplak, C.I. Bayly, I.R. Gould, K.M. Merz, Jr., D.M. Ferguson, D.C. Spellmeyer, T. Fox, J.W. Caldwell, and P.A. Kollman, A second generation force field for the simulation of proteins, nucleic acids, and organic molecules, J. Am. Chem. Soc. 117 (1995), pp. 5179-5197.
45. W.L. Jorgensen, D.S. Maxwell, and J. Tirado-Rives, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc. 118 (1996), pp. 11225-11236.
46. L.D. Schuler, X. Daura, and W.F. van Gunsteren, An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase, J. Comput. Chem. 22 (2001), pp. 1205-1218.
47. T.E. Cheatham, III, J.L. Miller, T. Fox, T.A. Darden, and P.A. Kollman, Molecular dynamics simulations on solvated biomolecular systems: The particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins, J. Am. Chem. Soc. 117 (1995), pp. 4193-4194.
48. J.P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen, Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes, J. Comput. Phys. 23 (1977), pp. 327-341.
49. S. Nose, A unified formulation of the constant temperature molecular-dynamics methods, J. Chem. Phys. 81 (1984), pp. 511-519.
50. W.G. Hoover, Canonical dynamics: Equilibrium phase-space distributions, Phys. Rev. A 31 (1985), pp. 1695-1697.
51. H.J.C. Berendsen, J.P.M. Postma, W.F. van Gunsteren, A. DiNola, and J.R. Haak, Molecular dynamics with coupling to an external bath, J. Chem. Phys. 81 (1984), pp. 3684-3690.
52. W.F. van Gunsteren and H.J.C. Berendsen, Computer simulation of molecular dynamics:Methodology, applications, and perspectives in chemistry, Angew. Chem. Int. Ed. 29 (1990), pp. 992-1023.
53. D.M. van Aalten, R. Bywater, J.B. Findlay, M. Hendlich, R.W. Hooft, and G. Vriend, PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules, J. Comput. Aided Mol. Des. 10 (1996), pp. 255-262.
54. J. Wang, W. Wang, P.A. Kollman, and D.A. Case, ANTECHAMBER: An accessory software package for molecular mechanical calculations, Abstr. Pap. Am. Chem. Soc. 222 (2001), p. U403.
55. V. Zoete, M.A. Cuendet, A. Grosdidier, and O. Michielin, SwissParam: A fast force field generation tool for small organic molecules, J. Comput. Chem. 32 (2011), pp. 2359-2368.
56. K. Vanommeslaeghe, E. Hatcher, C. Acharya, S. Kundu, S. Zhong, J. Shim, E. Darian, O. Guvench, P. Lopes, I. Vorobyov, and A.D. Mackerell, Jr., CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields, J. Comput. Chem. 31 (2010), pp. 671-690.
57. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 23 (1997), pp. 3-25.
58. S. Huo, J. Wang, P. Cieplak, P.A. Kollman, and I.D. Kuntz, Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: insight into structure-based ligand design, J. Med. Chem. 45 (2002), pp. 1412-1419.
59. P.A. Kollman, I. Massova, C. Reyes, B. Kuhn, S. Huo, L. Chong, M. Lee, T. Lee, Y. Duan, W. Wang, O. Donini, P. Cieplak, J. Srinivasan, D.A. Case, and T.E. Cheatham, 3rd, Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models, Acc. Chem. Res. 33 (2000), pp. 889-897.
60. T.P. Straatsma and J.A. McCammon, Computational alchemy, Annu. Rev. Phys. Chem. 43 (1992), pp. 407-435.
61. J. Aqvist, C. Medina, and J.E. Samuelsson, A new method for predicting binding affinity in computer-aided drug design, Protein Eng. 7 (1994), pp. 385-391.
62. J.M. Swanson, R.H. Henchman, and J.A. McCammon, Revisiting free energy calculations:A theoretical connection to MM/PBSA and direct calculation of the association free energy, Biophys. J. 86 (2004), pp. 67-74.
63. J. Srinivasan, T.E. Cheatham, P. Cieplak, P.A. Kollman, and D.A. Case, Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices, J. Am. Chem. Soc. 120 (1998), pp. 9401-9409.
64. M.S. Lee and M.A. Olson, Calculation of absolute protein-ligand binding affinity using path and endpoint approaches, Biophys. J. 90 (2006), pp. 864-877.
65. G.M. Torrie and J.P. Valleau, Nonphysical sampling distributions in Monte Carlo freeenergy estimation: umbrella sampling, J. Comput. Phys. 23 (1977), pp. 187-199.
66. S. Park, F. Khalili-Araghi, E. Tajkhorshid, and K. Schulten, Free energy calculation from steered molecular dynamics simulations using Jarzynski’s equality, J. Chem. Phys. 119 (2003), p. 3559.
67. A. Laio and M. Parrinello, Escaping free-energy minima, Proc. Natl. Acad. Sci. USA. 99 (2002), pp. 12562-12566.
68. M. Iannuzzi, A. Laio, and M. Parrinello, Efficient exploration of reactive potential energy surfaces using Car-Parrinello molecular dynamics, Phys. Rev. Lett. 90 (2003), p. 238302.
69. E. Darve, D. Rodriguez-Gomez, and A. Pohorille, Adaptive biasing force method for scalar and vector free energy calculations, J. Chem. Phys. 128 (2008), p. 144120.
70. D. Zhang, J. Gullingsrud, and J.A. McCammon, Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain, J. Am. Chem. Soc. 128 (2006), pp. 3019-3026.
71. S. Izrailev, S. Stepaniants, M. Balsera, Y. Oono, and K. Schulten, Molecular dynamics study of unbinding of the avidin-biotin complex, Biophys. J. 72 (1997), pp. 1568-1581.
72. B. Isralewitz, S. Izrailev, and K. Schulten, Binding pathway of retinal to bacterioopsin:A prediction by molecular dynamics simulations, Biophys. J. 73 (1997), pp. 2972-2979.
73. X. Huang, F. Zheng, and C.G. Zhan, Human butyrylcholinesterase-cocaine binding pathway and free energy profiles by molecular dynamics and potential of mean force simulations, J. Phys. Chem. B 115 (2011), pp. 11254-11260.
74. J. Du, H. Sun, L. Xi, J. Li, Y. Yang, H. Liu, and X. Yao, Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation, J. Comput. Chem. 32 (2011), pp. 2800-2809.
75. T. Yang, J.C. Wu, C. Yan, Y. Wang, R. Luo, M.B. Gonzales, K.N. Dalby, and P. Ren, Virtual screening using molecular simulations, Proteins 79 (2011), pp. 1940-1951.
76. C. Muñoz, F. Adasme, J.H. Alzate-Morales, A. Vergara-Jaque, T. Kniess, and J. Caballero, Study of differences on the VEGFR2 inhibitory activities between semaxanib and SU5205 by using 3D-QSAR, docking, and molecular dynamics simulations, J. Mol. Graph. Model. 32 (2012), pp. 39-48.
77. A.D. MacKerell, D. Bashford, M. Bellott, R.L. Dunbrack, J.D. Evanseck, M.J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy, L. Kuchnir, K. Kuczera, F.T.K. Lau, C. Mattos, S. Michnick, T. Ngo, D.T. Nguyen, B. Prodhom, W.E. Reiher, B. Roux, M. Schlenkrich, J.C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wiórkiewicz-Kuczera, D. Yin, and M. Karplus, All-Atom empirical potential for molecular modeling and dynamics studies of proteins, J. Phys. Chem. B 102 (1998), pp. 3586-3616.
78. E. Neria, S. Fisher, and M. Karplus, Simulation of activation free energies in molecular systems, J. Chem. Phys. 105 (1996), pp. 1902-1921.
79. L. Kale, R. Skeel, M. Bhandarkar, R. Brunner, A. Gursoy, N. Krawetz, J. Phillips, A. Shinozaki, K. Varadarajan, and K. Schulten, NAMD2: greater scalability for parallel molecular dynamics, J. Comput. Phys. 151 (1999), pp. 283-312.
80. W. Humphrey, A. Dalke, and K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph. 14 (1996), pp. 33-38.